Bristol-Myers Squibb Company vs Intuitive Surgical, Inc.
Vergleich der Marktkapitalisierung im Zeitverlauf
Bristol-Myers Squibb Company
$132.0B
Rang #127
Intuitive Surgical, Inc.
$139.8B
Rang #123
Marktkapitalisierung im Zeitverlauf
Wichtige Momente
- Intuitive Surgical, Inc. überholte Bristol-Myers Squibb Company bis 2021
- Bristol-Myers Squibb Company überholte Intuitive Surgical, Inc. bis 2022
- Intuitive Surgical, Inc. überholte Bristol-Myers Squibb Company bis 2023
Vergleich Jahr für Jahr
| Jahr | Bristol-Myers Squibb Company | Intuitive Surgical, Inc. | Spitzenreiter |
|---|---|---|---|
| 2026 | $132.0B | $139.8B | Intuitive Surgical, Inc. |
| 2025 | $107.8B | $200.6B | Intuitive Surgical, Inc. |
| 2024 | $107.6B | $184.9B | Intuitive Surgical, Inc. |
| 2023 | $92.9B | $119.5B | Intuitive Surgical, Inc. |
| 2022 | $125.8B | $94.0B | Bristol-Myers Squibb Company |
| 2021 | $105.8B | $127.3B | Intuitive Surgical, Inc. |
| 2020 | $102.0B | $96.6B | Bristol-Myers Squibb Company |
| 2019 | $102.4B | $69.8B | Bristol-Myers Squibb Company |
| 2018 | $80.2B | $56.5B | Bristol-Myers Squibb Company |
| 2017 | $92.0B | $43.1B | Bristol-Myers Squibb Company |
| 2016 | $85.4B | $25.0B | Bristol-Myers Squibb Company |
| 2015 | $98.2B | $21.5B | Bristol-Myers Squibb Company |
| 2014 | $82.3B | $20.8B | Bristol-Myers Squibb Company |
| 2013 | $72.0B | $15.1B | Bristol-Myers Squibb Company |
| 2012 | $42.7B | $19.3B | Bristol-Myers Squibb Company |
| 2011 | $44.4B | $18.2B | Bristol-Myers Squibb Company |
| 2010 | $31.8B | $10.1B | Bristol-Myers Squibb Company |
| 2009 | $28.9B | $11.9B | Bristol-Myers Squibb Company |
| 2008 | $25.1B | $5.0B | Bristol-Myers Squibb Company |
| 2007 | $27.1B | $12.7B | Bristol-Myers Squibb Company |
| 2006 | $25.9B | $3.8B | Bristol-Myers Squibb Company |
| 2005 | $21.6B | $4.6B | Bristol-Myers Squibb Company |
| 2004 | $23.0B | $1.6B | Bristol-Myers Squibb Company |
| 2003 | $24.5B | $672.5M | Bristol-Myers Squibb Company |
| 2002 | $19.0B | $484.8M | Bristol-Myers Squibb Company |
| 2001 | $40.3B | $789.4M | Bristol-Myers Squibb Company |
| 2000 | $54.6B | $669.0M | Bristol-Myers Squibb Company |